Skip to main content

People in the News: Aug 24, 2011


Bruce Taillon, formerly the director of healthcare business development at Roche's 454 Life Sciences division, is now the head of global technology business development at Enzo Life Science. While at 454, Taillon helped develop the company's next-generation sequencing platforms, including for its potential use in diagnostic assays. He also has experience leading R&D teams in the areas of genomics, proteomics, and drug development.

Pathogenica founder and CEO Yemi Adesokan has been named by MIT's Technology Review as one of its top innovators under the age of 35, for his work on developing sequencing-based diagnostic tests that can identify pathogens. His company is aiming to launch an FDA-approved test to diagnose HPV by 2012, and is also working on tests that can monitor drug resistance in HIV patients (CSN 8/17/2011). Previously, Adesokan was a research fellow in genetics at Harvard Medical School. He holds a PhD in chemistry from the University of California, Irvine.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.